Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunogenic and Protective Properties of Recombinant Hemagglutinin of Influenza A (H5N8) Virus.
Rudometova NB, Fando AA, Kisakova LA, Kisakov DN, Borgoyakova MB, Litvinova VR, Yakovlev VA, Tigeeva EV, Vahitov DI, Sharabrin SV, Shcherbakov DN, Evseenko VI, Ivanova KI, Gudymo AS, Ilyicheva TN, Marchenko VY, Ilyichev AA, Rudometov AP, Karpenko LI. Rudometova NB, et al. Among authors: borgoyakova mb. Vaccines (Basel). 2024 Jan 29;12(2):143. doi: 10.3390/vaccines12020143. Vaccines (Basel). 2024. PMID: 38400127 Free PMC article.
DNA Vaccine Encoding the Artificial T-Cell Polyepitope Immunogen of Tick-Borne Encephalitis Virus.
Kisakov DN, Antonets DV, Shaburova EV, Kisakova LA, Tigeeva EV, Yakovlev VA, Starostina EV, Borgoyakova MB, Protopopova EV, Svyatchenko VA, Loktev VB, Rudometov AP, Ilyichev AA, Nepomnyashchikh TS, Karpenko LI. Kisakov DN, et al. Among authors: borgoyakova mb. Bull Exp Biol Med. 2023 Nov;176(1):72-76. doi: 10.1007/s10517-023-05970-4. Epub 2023 Dec 13. Bull Exp Biol Med. 2023. PMID: 38091143
Artificial COVID-19 T-Cell Immunogen.
Borgoyakova MB, Karpenko LI, Rudometov AP, Starostina EV, Zadorozhny AM, Kisakova LA, Kisakov DN, Sharabrin SV, Ilyichev AA, Bazhan SI. Borgoyakova MB, et al. Bull Exp Biol Med. 2023 Oct;175(6):804-809. doi: 10.1007/s10517-023-05951-7. Epub 2023 Nov 18. Bull Exp Biol Med. 2023. PMID: 37979020
SARS-CoV-2 RBD Conjugated to Polyglucin, Spermidine, and dsRNA Elicits a Strong Immune Response in Mice.
Volosnikova EA, Merkuleva IA, Esina TI, Shcherbakov DN, Borgoyakova MB, Isaeva AA, Nesmeyanova VS, Volkova NV, Belenkaya SV, Zaykovskaya AV, Pyankov OV, Starostina EV, Zadorozhny AM, Zaitsev BN, Karpenko LI, Ilyichev AA, Danilenko ED. Volosnikova EA, et al. Among authors: borgoyakova mb. Vaccines (Basel). 2023 Apr 6;11(4):808. doi: 10.3390/vaccines11040808. Vaccines (Basel). 2023. PMID: 37112720 Free PMC article.
Immunogenicity of the DNA/Protein Combined Vaccine against COVID-19.
Borgoyakova MB, Karpenko LI, Merkulyeva IA, Shcherbakov DN, Rudometov AP, Starostina EV, Shanshin DV, Isaeva AA, Nesmeyanova VS, Volkova NV, Belenkaya SV, Volosnikova EA, Zadorozhny AM, Orlova LA, Zaykovskaya AV, Pyankov OV, Bazhan SI, Ilyichev AA. Borgoyakova MB, et al. Bull Exp Biol Med. 2022 Dec;174(2):246-249. doi: 10.1007/s10517-023-05682-9. Epub 2023 Jan 4. Bull Exp Biol Med. 2022. PMID: 36598669 Free PMC article.
Optimization of In Vivo Electroporation Conditions and Delivery of DNA Vaccine Encoding SARS-CoV-2 RBD Using the Determined Protocol.
Kisakov DN, Kisakova LA, Borgoyakova MB, Starostina EV, Taranov OS, Ivleva EK, Pyankov OV, Zaykovskaya AV, Shcherbakov DN, Rudometov AP, Rudometova NB, Volkova NV, Gureev VN, Ilyichev AA, Karpenko LI. Kisakov DN, et al. Among authors: borgoyakova mb. Pharmaceutics. 2022 Oct 22;14(11):2259. doi: 10.3390/pharmaceutics14112259. Pharmaceutics. 2022. PMID: 36365078 Free PMC article.
Enhancing the Immunogenicity of Vaccinia Virus.
Shchelkunov SN, Yakubitskiy SN, Sergeev AA, Starostina EV, Titova KA, Pyankov SA, Shchelkunova GA, Borgoyakova MB, Zadorozhny AM, Orlova LA, Kisakov DN, Karpenko LI. Shchelkunov SN, et al. Among authors: borgoyakova mb. Viruses. 2022 Jun 30;14(7):1453. doi: 10.3390/v14071453. Viruses. 2022. PMID: 35891430 Free PMC article.
Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines?
Merkuleva IA, Shcherbakov DN, Borgoyakova MB, Isaeva AA, Nesmeyanova VS, Volkova NV, Aripov VS, Shanshin DV, Karpenko LI, Belenkaya SV, Kazachinskaia EI, Volosnikova EA, Esina TI, Sergeev AA, Titova KA, Konyakhina YV, Zaykovskaya AV, Pyankov OV, Kolosova EA, Viktorina OE, Shelemba AA, Rudometov AP, Ilyichev AA. Merkuleva IA, et al. Among authors: borgoyakova mb. Viruses. 2022 May 16;14(5):1060. doi: 10.3390/v14051060. Viruses. 2022. PMID: 35632800 Free PMC article.
17 results